ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
Vanta Bioscience Ltd has issued notice for its upcoming Annual General Meeting scheduled for September 30, 2026, to transact key business resolutions.
Vanta Bioscience Ltd submitted its Annual Report and AGM notice for FY 2025-26. The 10th AGM is scheduled for September 30, 2026.
Vanta Bioscience approved the Annual Report for FY 2025-26 and scheduled the 10th Annual General Meeting for September 30, 2026.
Vanta Bioscience Ltd reported revenue from operations of ₹1.5 Cr (+400.0% YoY) and net profit of ₹1.9 Cr for H2 FY26.
Vanta Bioscience Limited approved audited standalone and consolidated financial results for FY2026. The board also re-appointed Mr. Dopesh Raja Mulakala as Managing Director for three years.
Vanta Bioscience scheduled a board meeting on May 30, 2026, to approve fiscal 2026 financial results. The trading window remains closed until June 1, 2026.